Monday, April 28, 2025

Latest

Aurora Cannabis Reiterates Guidance For Q1 2021

Aurora Cannabis (TSX: ACB) (NYSE: ACB) this morning reiterated guidance for the first quarter of fiscal 2021 in a brief update to the market. The guidance update was attached to the news that the company has filed a final short form base shelf prospectus in connection with the previously announced US$500 preliminary base shelf prospectus.

Guidance for the first quarter, although previously released, was reiterated with net cannabis revenues expected to be at the the “high end” of the previously provided $60 to $64 million range. This figure represents slightly reduced quarter over quarter earnings, with the fourth quarter seeing $67.5 million in revenue. The company expects revenue to be almost entirely from its cannabis operations.

Gross margin estimates were also provided, with the company expecting margins to be between 46% and 50%. SG&A expenses are meanwhile expected to be near $40 million, however this figure was provided on an adjusted basis, with the caveat being that it excludes “one-time contract and employee termination costs.” This caveat was not previously provided when the company provided guidance for the quarter.

Oddly, the company also indicated that its relationship with its lending syndicate “remains strong,” with no new obligations being present to repay portions of the outstanding facility prior to the maturity date. Aurora also indicated that it remains in compliance with all covenants as of September 30, 2020.

Finally, the company reiterated guidance in terms of profitability, restating that it continues to expect to report positive adjusted EBITDA for the second quarter of fiscal 2021.

The company is set to release first quarter financial results before market open on November 9.

Aurora Cannabis last traded at $4.09 on the NYSE.


Information for this briefing was found via Sedar and Aurora Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

Aurora Cannabis To Commence Trading On Nasdaq

Aurora Cannabis Inc. (TSX: ACB) (NASDAQ: ACB), last night reported that the company has completed...

Tuesday, May 25, 2021, 07:18:04 AM

Aurora Cannabis Sees Q4 Growth In Medical Cannabis While Consumer Segment Declines Materially

Aurora Cannabis (TSX: ACB) saw revenue of $67.4 million in its fiscal fourth quarter on...

Thursday, June 20, 2024, 08:27:10 AM

Visualizing the Aurora Cannabis Rollback

It’s times like this that The Dive‘s West Coast office is thankful or the under-rated...

Wednesday, April 15, 2020, 11:30:39 AM

Aurora Cannabis Names New CEO, Announces Over $1.8 Billion In Q4 Writedowns On Declining Revenues

Aurora Cannabis (TSX: ACB) (NYSE: ACB) this morning finally announced their new CEO, whom as...

Tuesday, September 8, 2020, 08:22:47 AM

Aurora Cannabis Sells Stake In Cann Group At Estimated 58.7% Loss

Aurora Cannabis (TSX: ACB) (NYSE: ACB) has taken a loss on yet another investment, with...

Monday, October 12, 2020, 12:32:32 PM